| abstract |
The description of the present invention relates to compounds and forms and pharmaceutical compositions and methods of use thereof for treating or ameliorating bacterial infections caused by wild-type and multi-drug resistant Gram negative and Gram positive pathogens. The description of the invention further relates to compounds having activity against wild-type and MDR bacteria. The description of the invention also relates to compounds having activity against quinolone resistant Gram negative strains (including MDR strains) as well as antibacterial activity against MDR resistant Gram positive pathogens (including MRSA strains). |